We are aware of current issues with the ONS login and account creation. At this time, account creation is unavailable. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
cancel
Androgen Receptor Signaling May Contribute to Melanoma Treatment Resistance
Elisa Becze, BA, ELS, Editor
Voice
Description
Poorer outcomes among males receiving BRAF or MEK inhibitors for melanoma may be related to an increase in androgen receptors, researchers discovered in study findings published in Nature.